ACE inhibitors are beneficial for many patients at risk for heart disease
December 1999
A new landmark study shows that ACE inhibitors are beneficial for many patients at risk for heart disease.
We already know they improve survival in patients with systolic heart failure...or a recent MI.
Now there's evidence the ACE inhibitor ramipril (Altace) reduces morbidity and mortality for a broad spectrum of patients with atherosclerosis or diabetes.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote